CODX Strangle Strategy

CODX (Co-Diagnostics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

CODX (Co-Diagnostics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.7M, a beta of 2.88 versus the broader market, a 52-week range of 1.26-46.5, average daily share volume of 5.8M, a public-listing history dating back to 2017, approximately 115 full-time employees. These structural characteristics shape how CODX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.88 indicates CODX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a strangle on CODX?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

CODX snapshot

As of August 14, 2026, spot at $1.42, ATM IV 35.20%, IV rank 4.05%, expected move 10.09%. The strangle on CODX below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 7-day expiry.

Why this strangle structure on CODX specifically: CODX IV at 35.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a CODX strangle, with a market-implied 1-standard-deviation move of approximately 10.09% (roughly $0.14 on the underlying). The 7-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CODX expiries trade a higher absolute premium for lower per-day decay. Position sizing on CODX should anchor to the underlying notional of $1.42 per share and to the trader's directional view on CODX stock.

CODX strangle setup

The CODX strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CODX at $1.42 on that close, the first option leg uses a $1.49 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CODX chain at a 7-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CODX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$1.49N/A
Buy 1Put$1.35N/A

CODX strangle risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

CODX strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on CODX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on CODX

Strangles on CODX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CODX chain.

CODX thesis for this strangle

The market-implied 1-standard-deviation range for CODX extends from approximately $1.28 on the downside to $1.56 on the upside. A CODX long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CODX IV rank near 4.05% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CODX at 35.20%. As a Healthcare name, CODX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CODX-specific events.

CODX strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CODX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CODX alongside the broader basket even when CODX-specific fundamentals are unchanged. Always rebuild the position from current CODX chain quotes before placing a trade.

Frequently asked questions

What is a strangle on CODX?
A strangle on CODX is the strangle strategy applied to CODX (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CODX stock at $1.42 on the most recent close, the strikes shown on this page are snapped to the nearest listed CODX chain strike and the premiums come straight from that session's bid/ask midpoint.
How are CODX strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CODX strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 35.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CODX strangle?
The breakeven for the CODX strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CODX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on CODX?
Strangles on CODX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CODX chain.
How does current CODX implied volatility affect this strangle?
CODX ATM IV is at 35.20% with IV rank near 4.05%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related CODX analysis